Exome Sequencing Study Uncovers Risk Gene for Uterine Fibroids | GenomeWeb

By Andrea Anderson

NEW YORK (GenomeWeb News) – A transcription regulating gene called MED12 is frequently mutated in a type of benign uterine tumors called uterine leiomyomas, or fibroids, according to an exome-sequencing study in the early, online version of Science today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.